Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRIT 2: Relugolix in Endometriosis-Associated Pain
NCT03204331Phase 3Completed
- Sponsor
- Myovant Sciences
- Start
- Nov 2017
- Primary completion
- Apr 2020
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 11
01
Overview
A Phase 3 trial of relugolix in endometriosis, sponsored by Myovant Sciences. Started Nov 2017; status: completed.
02
Drugs
relugolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03204331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03204331.